Takeaway

• Venous thromboembolism (VTE) is common in the setting of cancer and is increasing over time.
• Risk stratification is crucial to balance risks and benefits of primary thromboprophylaxis.
• Management of cancer-associated thrombosis (CAT) is specific for different time-points in the course of cancer.
• Risk-benefit analysis of anticoagulation must be regularly...